AstraZeneca and Eli Lilly scrap Alzheimer’s drug trial

Duo’s tests of lanabecestat halted as primary targets ‘not likely’ to be met
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news